Exosome-based Revolution: Exploring the Potential of Diagnostic and Therapeutic Applications in the Emerging Exosome.
PORTLAND, OREGON, UNITED STATES, April 18, 2023 /EINPresswire.com/ -- Exosomes are tiny structures that are naturally produced by cells in our body. They contain different types of molecules, such as proteins, lipids, and nucleic acids, that can provide valuable information about the health status of the cells that produce them.
In terms of diagnostics, exosomes can be isolated from body fluids such as blood, urine, or cerebrospinal fluid and analyzed to detect diseases or monitor disease progression. By studying the contents of exosomes, doctors and researchers can identify specific biomarkers that indicate the presence of a disease, such as cancer or neurological disorders.
In terms of therapeutics, exosomes can be harnessed as a tool for delivering drugs or therapeutic molecules to specific cells or tissues. Researchers are exploring the use of exosomes as a drug delivery system because they are naturally produced by cells and are able to cross biological barriers, such as the blood-brain barrier. Additionally, exosomes are less likely to be rejected by the immune system compared to other delivery systems, such as viruses or liposomes.
Overall, exosomes have the potential to revolutionize both diagnostics and therapeutics by providing a non-invasive way to detect diseases and delivering targeted treatments.
According to the report, the global exosome diagnostic and therapeutic industry was estimated at $224.34 million in 2020, and is anticipated to hit $2.9 billion by 2030, registering a CAGR of 29.4% from 2021 to 2030.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/request-sample/1723
๐๐ก๐ ๐๐ฑ๐จ๐ฌ๐จ๐ฆ๐ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐ ๐๐ง๐ ๐ญ๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐๐๐ง ๐๐ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ ๐ข๐ง๐ญ๐จ ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐๐๐ญ๐๐ ๐จ๐ซ๐ข๐๐ฌ ๐๐๐ฌ๐๐ ๐จ๐ง ๐๐ข๐๐๐๐ซ๐๐ง๐ญ ๐๐๐๐ญ๐จ๐ซ๐ฌ, ๐ฌ๐ฎ๐๐ก ๐๐ฌ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง, ๐ฌ๐จ๐ฎ๐ซ๐๐, ๐ฉ๐ซ๐จ๐๐ฎ๐๐ญ ๐ญ๐ฒ๐ฉ๐, ๐๐ง๐ ๐๐ง๐-๐ฎ๐ฌ๐๐ซ.
Application-wise, the market can be segmented into cancer, neurodegenerative diseases, cardiovascular diseases, infectious diseases, and others. Exosomes can be used as biomarkers for the early detection and diagnosis of these diseases, as well as for monitoring disease progression and treatment response.
Source-wise, the market can be segmented into natural exosomes and hybrid exosomes. Natural exosomes are isolated directly from biological fluids or tissues, while hybrid exosomes are engineered or modified to contain specific cargo for therapeutic purposes.
Product type-wise, the market can be segmented into reagents, instruments, and services. Reagents include isolation and purification kits, labeling kits, and analysis kits. Instruments include centrifuges, microscopes, and flow cytometers, among others. Services include exosome isolation, characterization, and profiling.
End-user-wise, the market can be segmented into academic and research institutes, pharmaceutical and biotechnology companies, and hospitals and diagnostic centers.
These are some of the main segments that are typically used to classify the exosome diagnostic and therapeutic market.
๐๐จ๐ฏ๐ข๐-๐๐ ๐ฌ๐๐๐ง๐๐ซ๐ข๐จ:
Rapid spread of Covid-19 heightened the need for molecular diagnosis, thus impacting the global exosome diagnostic and therapeutic market positively.
This trend is pretty likely to continue till the pandemic is completely over.
๐๐ฌ๐ค ๐ญ๐จ ๐๐ฎ๐ซ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ฑ๐ฉ๐๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/1723
๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐ ๐ ๐๐ซ๐ง๐๐ซ๐๐ ๐ญ๐ก๐ ๐ฆ๐๐ฃ๐จ๐ซ ๐ฌ๐ก๐๐ซ๐ ๐ข๐ง ๐๐๐๐-
Based on region, North America held the major share in 2020, generating nearly two-fifths of the global exosome diagnostic and therapeutic market, due to rise in product launches for exosome therapeutics, surge in the presence of key players, and development of R&D activities in the pharmaceutical and biopharmaceutical sector across the province. Asia-Pacific, however, would grow at the fastest CAGR of 30.3% by 2030. Increase in the prevalence of chronic and infectious disorders, growth in health care expenditures, and surge in demand for molecular diagnosis drive the market growth in the region.
๐๐๐ซ๐ ๐๐ซ๐ ๐ญ๐ก๐ ๐ญ๐จ๐ฉ ๐๐ ๐ค๐๐ฒ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐ฑ๐จ๐ฌ๐จ๐ฆ๐ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐ ๐๐ง๐ ๐ญ๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐ ๐ฆ๐๐ซ๐ค๐๐ญ, ๐๐๐ฌ๐๐ ๐จ๐ง ๐ญ๐ก๐๐ข๐ซ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฌ๐ก๐๐ซ๐, ๐ฉ๐ซ๐จ๐๐ฎ๐๐ญ ๐จ๐๐๐๐ซ๐ข๐ง๐ ๐ฌ, ๐๐ง๐ ๐ข๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐จ๐ง:
Thermo Fisher Scientific Inc.
Qiagen N.V.
Bio-Techne Corporation
System Biosciences, LLC
NX Prenatal Inc.
NanoSomiX Inc.
Norgen Biotek Corp.
Malvern Panalytical Ltd.
HansaBioMed Life Sciences Ltd.
AMS Biotechnology (Europe) Limited
๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ (๐๐จ๐จ๐ค ๐๐จ๐ฐ ๐ฐ๐ข๐ญ๐ก ๐๐% ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ):
Esophagoscopes and Gastroscopes Market
Computer-Aided Drug Discovery Market
๐๐๐จ๐ฎ๐ญ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
David Correa
Allied Analytics LLP
+1-800-792-5285
email us here